Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiya Inaba

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Nature Communications|September 28, 2017
Priming of lineage-specifying genes by Bcl11b is required for lineage choice in post-selection thymocytesSatoshi Kojo, Hirokazu Tanaka, Takaho A Endo, et al.
Hepatology (Baltimore, Md.)|June 1, 2011
Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivoNobuhiko Hiraga, Michio Imamura, Hiromi Abe, et al.
Antimicrobial Agents and Chemotherapy|January 29, 2014
Ultradeep sequencing study of chronic hepatitis C virus genotype 1 infection in patients treated with daclatasvir, peginterferon, and ribavirinEisuke Murakami, Michio Imamura, C Nelson Hayes, et al.
Nature Communications|June 24, 2014
Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformationGoro Sashida, Hironori Harada, Hirotaka Matsui, et al.
Leukemia|October 13, 2022
DDX41 coordinates RNA splicing and transcriptional elongation to prevent DNA replication stress in hematopoietic cellsSatoru Shinriki, Mayumi Hirayama, Akiko Nagamachi, et al.
The Journal of Biological Chemistry|November 1, 2012
Role of Pin1 protein in the pathogenesis of nonalcoholic steatohepatitis in a rodent modelYusuke Nakatsu, Yuichiro Otani, Hideyuki Sakoda, et al.
Molecular Cancer Therapeutics|September 24, 2017
A Chemical Modulator of p53 Transactivation that Acts as a Radioprotective AgonistAkinori Morita, Ippei Takahashi, Megumi Sasatani, et al.
Gut|January 17, 2013
Combination therapies with NS5A, NS3 and NS5B inhibitors on different genotypes of hepatitis C virus in human hepatocyte chimeric miceNiu Shi, Nobuhiko Hiraga, Michio Imamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2020
<i>Kdm6a</i> Deficiency Activates Inflammatory Pathways, Promotes M2 Macrophage Polarization, and Causes Bladder Cancer in Cooperation with <i>p53</i> DysfunctionKohei Kobatake, Ken-Ichiro Ikeda, Yuichiro Nakata, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 18, 2026
Angiotensin II type 1 receptor signaling promotes bladder cancer progression and its inhibition by LosartanRyoken Yamanaka, Kento Miura, Norimasa Yamasaki, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Nature Communications|September 28, 2017
Priming of lineage-specifying genes by Bcl11b is required for lineage choice in post-selection thymocytesSatoshi Kojo, Hirokazu Tanaka, Takaho A Endo, et al.
Hepatology (Baltimore, Md.)|June 1, 2011
Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivoNobuhiko Hiraga, Michio Imamura, Hiromi Abe, et al.
Antimicrobial Agents and Chemotherapy|January 29, 2014
Ultradeep sequencing study of chronic hepatitis C virus genotype 1 infection in patients treated with daclatasvir, peginterferon, and ribavirinEisuke Murakami, Michio Imamura, C Nelson Hayes, et al.
Nature Communications|June 24, 2014
Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformationGoro Sashida, Hironori Harada, Hirotaka Matsui, et al.
Leukemia|October 13, 2022
DDX41 coordinates RNA splicing and transcriptional elongation to prevent DNA replication stress in hematopoietic cellsSatoru Shinriki, Mayumi Hirayama, Akiko Nagamachi, et al.
The Journal of Biological Chemistry|November 1, 2012
Role of Pin1 protein in the pathogenesis of nonalcoholic steatohepatitis in a rodent modelYusuke Nakatsu, Yuichiro Otani, Hideyuki Sakoda, et al.
Molecular Cancer Therapeutics|September 24, 2017
A Chemical Modulator of p53 Transactivation that Acts as a Radioprotective AgonistAkinori Morita, Ippei Takahashi, Megumi Sasatani, et al.
Gut|January 17, 2013
Combination therapies with NS5A, NS3 and NS5B inhibitors on different genotypes of hepatitis C virus in human hepatocyte chimeric miceNiu Shi, Nobuhiko Hiraga, Michio Imamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2020
<i>Kdm6a</i> Deficiency Activates Inflammatory Pathways, Promotes M2 Macrophage Polarization, and Causes Bladder Cancer in Cooperation with <i>p53</i> DysfunctionKohei Kobatake, Ken-Ichiro Ikeda, Yuichiro Nakata, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 18, 2026
Angiotensin II type 1 receptor signaling promotes bladder cancer progression and its inhibition by LosartanRyoken Yamanaka, Kento Miura, Norimasa Yamasaki, et al.
Pageof 9